ARCHIVES

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 18 | May 4, 2001

Download PDF Visit The Full Archive

Related Articles

CMS Launches National Coverage Analysis, Citing FDA’s Black Box Warning on ESAs.

March 16, 2007

5-Day Strut-based Brachytherapy Produced Low Recurrence Rates

May 25, 2012

NCI Cooperative Group Clinical Trials Approved

December 25, 2009

Study Finds No Link Between Tumor Grade and Relapse Risk

February 25, 2011

AICR Increasing Funds for Research, Education, Supports Successful Symposium

November 7, 1986

Clinical Trials Approved By NCI CTEP Last Month

January 28, 2011